Short answer
Companies track substances across markets by linking substance data to products, materials, suppliers, uses, jurisdictions, regulatory status, and source evidence. The challenge is that a substance can be treated differently depending on market, product category, concentration, use case, and stage of regulatory action.
The Data Model Matters
A useful system needs more than a list of chemical names. Teams need identifiers, grouping logic, products or materials where the substance appears, market scope, supplier evidence, and source-linked regulatory status.
Where data is incomplete, the system should preserve uncertainty rather than quietly treating unknown exposure as no exposure.
Why Manual Tracking Breaks Down
A spreadsheet may work for one market and a short list of substances. It becomes difficult when the same substance appears in multiple products, under different rules, in different markets, with different review owners.
That is where source traceability and workflow become as important as the substance list itself.
Frequently asked questions
Do teams need perfect substance data to start?
No. Teams can start with known high-priority substances and improve the model as supplier and product data improves.
Should substance groups be tracked separately from named substances?
Often yes. Group-level rules and named-substance rules can create different monitoring and exposure questions.
Related questions
What is a substance watch list?
The monitored substances and groups your team cannot afford to lose track of.
Read moreHow should product stewardship teams monitor PFAS?
PFAS is a family-level monitoring problem, not a single-substance watch.
Read moreHow does Foresight map alerts to products and substances?
Mapping is the bridge between a regulatory update and business exposure.
Read more